La Jolla Pharmaceutical Company

YTD

ALL

Why Robinhood?

You can watch LJPC and buy or sell other stocks, options, and ETFs commission-free!

About LJPC

La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics for chronic organ failure and cancer. GCS-100, the Company's lead product candidate, is a first-in-class inhibitor of galectin-3, a novel molecular target implicated in chronic organ failure and cancer.

CEO

Larry G. Edwards

CEOLarry G. Edwards

Employees

—

Employees—

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

1989

Founded1989

Employees

—

Employees—

LJPC Key Statistics

Market cap

158.96M

Market cap158.96M

Price-Earnings ratio

59.18

Price-Earnings ratio59.18

Dividend yield

—

Dividend yield—

Average volume

511.79K

Average volume511.79K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$6.24

52 Week high$6.24

52 Week low

$3.07

52 Week low$3.07